Results 31 to 40 of about 568,486 (233)

Involvement of Cytokines in the Pathogenesis of Diabetic Macular Edema

International Journal of Molecular Sciences, 2021
Diabetic macular edema (DME) is a critical complication of diabetic retinopathy, a condition that arises from the breakdown of the blood–retinal barrier and the consequent increase in vascular permeability.
H. Noma, K. Yasuda, M. Shimura
semanticscholar   +1 more source

Optical coherence tomography fast versus regular macular thickness mapping in diabetic retinopathy [PDF]

, 2008
Objective: The purpose of the study was to investigate if absolute values and reproducibility of thickness maps obtained from 2 optical coherence tomography (OCT) scanning protocols, regular high-resolution and fast low-density mode, differ in patients ...
Ceklic, Lala, Maar, Noemi, Neubauer, Aljoscha Steffen   +2 more
core   +1 more source

Combined poor diabetes control indicators are associated with higher risks of diabetic retinopathy and macular edema than poor glycemic control alone.

PLoS ONE, 2017
PurposeTo examine the association of individual and combined indicators of diabetes control with diabetic retinopathy and diabetic macular edema.Materials and methodsIn this clinical, cross-sectional study, 613 adults with type 2 diabetes (372 any ...
Eva K Fenwick, Jing Xie, Ryan E K Man, Charumathi Sabanayagam, Lyndell Lim, Gwyn Rees, Tien Y Wong, Ecosse L Lamoureux   +7 more
doaj   +1 more source

Topical treatment of diabetic macular edema using dexamethasone ophthalmic suspension: A randomized, double‐masked, vehicle‐controlled study

Acta ophthalmologica, 2022
To evaluate topical dexamethasone ophthalmic suspension OCS‐01 (Oculis SA, Lausanne, Switzerland) in diabetic macular edema (DME).
E. Stefánsson, T. Loftsson, M. Larsen, A. Papp, K. Kaarniranta, M. Munk, P. Dugel, R. Tadayoni   +7 more
semanticscholar   +1 more source

Alpha-Lipoic Acid for the Prevention of Diabetic Macular Edema [PDF]

, 2011
Introduction: To evaluate the effect of alpha-lipoic acid (ALA) on the occurrence of diabetic macular edema. Methods: Randomized, double-blind, placebo-controlled, multicenter, multinational study. Patients were randomized to the treatment group with 600
Haritoglou, Christos, Anselm Kampik, Joachim Gerss, Gerss, Joachim, Hammes, Hans P., Ulbig, Michael W., null null, Christos Haritoglou, Kampik, Anselm, Hans P. Hammes, Michael W. Ulbig   +10 more
core   +1 more source

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss

Eye and Vision, 2015
Diabetic retinopathy (DR) is a leading cause of vision-loss globally. Of an estimated 285 million people with diabetes mellitus worldwide, approximately one third have signs of DR and of these, a further one third of DR is vision-threatening DR ...
Ryan Lee, T. Wong, C. Sabanayagam
semanticscholar   +1 more source

Intravitreal Pharmacotherapies for Diabetic Macular Edema: A Report by the American Academy of Ophthalmology.

Ophthalmology (Rochester, Minn.), 2021
PURPOSE To review the evidence on the safety and efficacy of current anti-vascular endothelial growth factor (VEGF) and intravitreal corticosteroid pharmacotherapies for the treatment of diabetic macular edema (DME).
Justis P. Ehlers, S. Yeh, M. Maguire, Justine R. Smith, Prithvi Mruthyunjaya, Nieraj Jain, L. Kim, Christina Y. Weng, C. Flaxel, S. Schoenberger, Stephen J. Kim   +10 more
semanticscholar   +1 more source

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-year Results from a Comparative Effectiveness Randomized Clinical Trial

Ophthalmology (Rochester, Minn.), 2016
Purpose Provide 2-year efficacy, safety and treatment results comparing three anti-vascular endothelial growth factor (anti-VEGF) agents for center-involved diabetic macular edema (DME) utilizing a standardized follow-up and retreatment regimen.
J. A. Wells, A. Glassman, Allison R. Ayala, Lee M. Jampol, Neil M. Bressler, S. Bressler, Alexander J. Brucker, Frederick L. Ferris, G. R. Hampton, Chirag Jhaveri, M. Melia, Roy W. Beck   +11 more
semanticscholar   +1 more source

Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA)

Ophthalmologica, 2017
Diabetic retinal disease is envisioned to become the plague of the coming decades with a steep increase of worldwide diabetes incidence followed by a substantial rise in retinal disease.
U. Schmidt-Erfurth, J. Garcia-Arumi, F. Bandello, K. Berg, U. Chakravarthy, B. Gerendas, J. Jonas, M. Larsen, R. Tadayoni, A. Loewenstein   +9 more
semanticscholar   +1 more source

CANet: Cross-Disease Attention Network for Joint Diabetic Retinopathy and Diabetic Macular Edema Grading [PDF]

IEEE Transactions on Medical Imaging, 2019
Diabetic retinopathy (DR) and diabetic macular edema (DME) are the leading causes of permanent blindness in the working-age population. Automatic grading of DR and DME helps ophthalmologists design tailored treatments to patients, thus is of vital ...
X. Li, Xiao-Wei Hu, Lequan Yu, Lei Zhu, Chi-Wing Fu, Pheng-Ann Heng   +5 more
semanticscholar   +1 more source